Influencing factors and drug application of iontophoresis in transdermal drug delivery: an overview of recent progress
- PMID: 33486687
- DOI: 10.1007/s13346-021-00898-6
Influencing factors and drug application of iontophoresis in transdermal drug delivery: an overview of recent progress
Abstract
Transdermal drug delivery is limited by the stratum corneum of skin, which blocks most molecules, and thus, only few molecules with specific physicochemical properties (molecular weight < 500 Da, adequate lipophilicity, and low melting point) are able to penetrate the skin. Recently, various technologies have been developed to overcome the strong barrier properties of stratum corneum. Iontophoresis technology, which uses a small current to improve drug permeation through skin, is one of the effective ways to circumvent the stratum corneum. This approach not only provides a more efficient, noninvasive, and patient-friendly method of drug delivery but also widens the scope of drugs for transdermal delivery. In this review, the mechanisms underlying iontophoresis and affecting factors are outlined. The focus will be on the latest advancements in iontophoretic transdermal drug delivery and application of iontophoresis with other enhancing technologies. The challenges of this technology for drug administration have also been highlighted, and some iontophoretic systems approved for clinical use are described.
Keywords: Combination; Drug delivery; Electric current; Iontophoresis; Transdermal.
© 2021. Controlled Release Society.
Similar articles
-
Transdermal iontophoretic drug delivery: advances and challenges.J Drug Target. 2016;24(5):386-91. doi: 10.3109/1061186X.2015.1090442. Epub 2015 Sep 25. J Drug Target. 2016. PMID: 26406291 Review.
-
Diagnostic and therapeutic applications of iontophoresis.J Drug Target. 2009 Nov;17(9):690-700. doi: 10.3109/10611860903089750. J Drug Target. 2009. PMID: 19845485 Review.
-
Iontophoretic drug delivery.Adv Drug Deliv Rev. 2004 Mar 27;56(5):619-58. doi: 10.1016/j.addr.2003.10.026. Adv Drug Deliv Rev. 2004. PMID: 15019750 Review.
-
Iontophoresis for the cutaneous delivery of nanoentraped drugs.Expert Opin Drug Deliv. 2023 Jun;20(6):785-798. doi: 10.1080/17425247.2023.2209719. Epub 2023 May 3. Expert Opin Drug Deliv. 2023. PMID: 37119173 Review.
-
Enhanced Transdermal Drug Delivery by Sonophoresis and Simultaneous Application of Sonophoresis and Iontophoresis.AAPS PharmSciTech. 2019 Jan 29;20(3):96. doi: 10.1208/s12249-019-1309-z. AAPS PharmSciTech. 2019. PMID: 30694397
Cited by
-
Transdermal Delivery of Therapeutic Compounds With Nanotechnological Approaches in Psoriasis.Front Bioeng Biotechnol. 2022 Jan 24;9:804415. doi: 10.3389/fbioe.2021.804415. eCollection 2021. Front Bioeng Biotechnol. 2022. PMID: 35141215 Free PMC article. Review.
-
The application of corticosteroids for pathological scar prevention and treatment: current review and update.Burns Trauma. 2023 Mar 18;11:tkad009. doi: 10.1093/burnst/tkad009. eCollection 2023. Burns Trauma. 2023. PMID: 36950503 Free PMC article.
-
Advance and Challenges in the Treatment of Skin Diseases with the Transdermal Drug Delivery System.Pharmaceutics. 2023 Aug 21;15(8):2165. doi: 10.3390/pharmaceutics15082165. Pharmaceutics. 2023. PMID: 37631379 Free PMC article. Review.
-
Iontophoresis-driven microneedle patch for the active transdermal delivery of vaccine macromolecules.Microsyst Nanoeng. 2023 Mar 27;9:35. doi: 10.1038/s41378-023-00515-1. eCollection 2023. Microsyst Nanoeng. 2023. PMID: 36987502 Free PMC article.
-
Advancements in Transdermal Drug Delivery Systems: Harnessing the Potential of Macromolecular Assisted Permeation Enhancement and Novel Techniques.AAPS PharmSciTech. 2025 Jan 9;26(1):29. doi: 10.1208/s12249-024-03029-9. AAPS PharmSciTech. 2025. PMID: 39789371 Review.
References
-
- Hadgraft J, Lane ME. Passive transdermal drug delivery systems. Am J Drug Deliv. 2006;4(3):153–60. - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources